Table 2.
Demographics and clinical characteristics of the experimental and control groups of the trials included in the systematic review.
| Study | Group | Subjects [N] | Sex [N Male; Female] | Age(y) [M; SD] | FEV1 L/%pred [M; SD] | FVC1 L/%pred [M; SD] |
|---|---|---|---|---|---|---|
| Ref. [36] | TR | 100 | 35; 65 | 69.43; 7.38 | -/39.55; 15.13 | - |
| CI | 100 | 32; 68 | 68.87; 5.33 | -/38.65; 13.68 | - | |
| Ref. [26] | TR | 64 | 41; 23 | 69.10; 7.90 | -/58.00; 23.60 | -/88.40; 22.00 |
| CI | 26 | 18; 8 | 71.40; 8.60 | -/60.50; 20.10 | -/83.20; 21.20 | |
| Ref. [37] | TR | 27 | 16; 11 | 67.40; 10.20 | -/36.10; 14.10 | -/67.40; 19.90 |
| CI | 27 | 15; 12 | 72.50; 7.40 | -/32.80; 8.50 | -/70.20; 17.00 | |
| Ref. [34] | TR | 171 | 111; 60 | 66.00; 8.00 | -/55.00; 20.00 | - |
| NI | 172 | 108; 64 | 67.00; 8.00 | -/57.00; 21.00 | - | |
| Ref. [38] | TR | 46 | 30; 16 | 62.30; 8.20 | -/42.39; 13.49 | -/73.38; 15.88 |
| CI | 48 | 33; 15 | 63.00; 6.60 | -/42.93; 13.78 | -/74.50; 15.47 | |
| Ref. [40] | TR | 67 | 32; 35 | 68.40; 8.70 | -/32.60; 10.30 | - |
| CI | 67 | 28; 39 | 68.20; 9.40 | -/33.70; 8.40 | - | |
| Ref. [32] | TR | 80 | 48; 32 | 69.00; 13.00 | -/52.00; 19.00 | -/78.00; 17.00 |
| CI | 86 | 51; 35 | 69.00; 10.00 | -/49.00; 19.00 | -/79.00; 22.00 | |
| Ref. [25] | TR | 53 | 44; 9 | 70.92; 6.38 | - | - |
| CI | 53 | 43; 10 | 71.83; 7.60 | - | - | |
| Ref. [24] | TR | 12 | 10; 2 | 74.00; 8.00 | -/58.00; 23.20 | 2.80; 0.70/- |
| CI | 15 | 14; 1 | 75.00; 9.00 | -/60.60; 20.80 | 3.20; 0.70/- | |
| Ref. [27] | TR | 29 | 17; 12 | 68.00; 9.00 | -/90.00; 8.00 | -/104.00; 8.00 |
| NI | 29 | 17; 12 | 67.00; 10.00 | -/92.00; 7.00 | -/104.00; 24.00 | |
| Ref. [28] | TR | 10 | 4; 6 | 73.00; 4.00 | 1.00; 0.30/- | - |
| NI | 10 | 3; 7 | 67.00; 8.00 | 0.90; 0.20/- | - | |
| Ref. [39] | TR | 50 | 41; 9 | 65.90; 8.90 | -/48.70; 11.20 | 0.00; 11.20/- |
| CI1 | 50 | 38; 12 | 65.60; 8.80 | -/50.40; 11.40 | -/50.30; 11.40 | |
| CI2 | 50 | 37; 13 | 64.80; 9.30 | -/47.40; 11.50 | -/48.40; 10.30 | |
| Ref. [31] | TR | 29 | 21; 8 | 69.40; 3.30 | -/49.20; 0.50 | 1.70; 0.00/- |
| NI | 28 | 23; 5 | 68.80; 1.40 | -/49.80; 0.70 | 1.80; 0.00/- | |
| Ref. [22] | TR | 33 | 27; 6 | 66.40; 9.50 | -/47.50; 23.30 | -/68.70; 30.20 |
| CI | 23 | 19; 4 | 71.30; 6.70 | -/51.50; 23.90 | -/79.10; 30.00 | |
| NI | 29 | 19; 10 | 70.80; 8.70 | -/41.40; 18.40 | -/69.90; 28.00 | |
| Ref. [41] | TR | 22 | 19; 3 | 70.40; 9.40 | -/61.00; 18.70 | - |
| NI | 20 | 14; 6 | 65.06; 11.10 | -/69.40; 24.00 | - | |
| Ref. [29] | TR | 10 | 9; 1 | 69.20; 5.41 | -/64.60; 11.97 | - |
| NI | 10 | 10; 0 | 67.40; 6.60 | -/60.40; 20.14 | - | |
| Ref. [23] | TR | 17 | 7; 10 | 65.00; - | -/61.40 | - |
| CI | 19 | 3; 16 | 64.00; - | -/58.00 | - | |
| Ref. [33] | TR | 19 | 12; 7 | 73.00; 8.00 | -/60.00; 23.00 | -/89.00; 25.00 |
| NI | 17 | 6; 11 | 75.00; 9.00 | -/68.00; 19.00 | -/98.00; 17.00 | |
| Ref. [8] | TR | 47 | 44; 3 | 66.90; 9.60 | -/49.60; 21.90 | -/80.70; 20.20 |
| CI | 50 | 38; 12 | 66.70; 7.30 | -/51.80; 17.30 | -/78.40; 18.40 | |
| NI | 50 | 37; 13 | 64.00; 8.00 | -/51.70; 21.00 | -/80.00; 20.30 | |
| Ref. [21] | TR | 84 | 42; 42 | 62.00; 9.00 | -/59.00; 20.00 | -/101.00; 20.00 |
| NI | 73 | 37; 36 | 63.00; 8.00 | -/53.00; 15.00 | -/99.00; 19.00 | |
| Ref. [35] | TR | 55 | 21; 34 | 69.30; 7.80 | 0.40; 1.20/- | 0.50; 0.20/- |
| NI | 65 | 36; 29 | 71.80; 8.10 | 0.30; 0.10/- | 0.50; 0.20/- | |
| Ref. [30] | TR | 23 | - | 67.50; 6.20 | -/46.70; 13.50 | 2.20; 0.70/- |
| CI1 | 23 | - | 68.30; 7.00 | -/42.60; 12.00 | 2.10; 0.80/- | |
| CI2 | 23 | - | 67.20; 7.30 | -/47.20; 12.40 | 2.30; 0.60/- | |
| CI3 | 23 | - | 69.40; 6.40 | -/48.20; 15.00 | 2.30; 0.80/- |
Legend: CI, conventional intervention; COPD, chronic obstructive pulmonary disease; M, mean; N, number; NI, no intervention; SD, standard deviation; TR, telerehabilitation.